Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
Diffuse midline glioma (DMG), including tumors diagnosed in the brainstem (diffuse intrinsic
pontine glioma-DIPG), is the primary cause of brain tumor-related death in pediatric patients …
pontine glioma-DIPG), is the primary cause of brain tumor-related death in pediatric patients …
Tumor and immune cell types interact to produce heterogeneous phenotypes of pediatric high-grade glioma
Background Pediatric high-grade gliomas (PHGG) are aggressive brain tumors with 5-year
survival rates ranging from< 2% to 20% depending upon subtype. PHGG presents differently …
survival rates ranging from< 2% to 20% depending upon subtype. PHGG presents differently …
Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas
G Pericoli, A Galardi, A Paolini, LL Petrilli, G Pepe… - Cell & Bioscience, 2023 - Springer
Abstract Background Paediatric-type diffuse High-Grade Gliomas (PDHGG) are highly
heterogeneous tumours which include distinct cell sub-populations co-existing within the …
heterogeneous tumours which include distinct cell sub-populations co-existing within the …
Applications and current challenges of chimeric antigen receptor T cells in treating high-grade gliomas in adult and pediatric populations
High-grade gliomas (HGGs) continue to be some of the most devastating diseases in the
USA. Despite extensive efforts, the survival of HGG patients has remained relatively …
USA. Despite extensive efforts, the survival of HGG patients has remained relatively …
Glial fibrillary acidic protein, neurofilament light, matrix metalloprotease 3 and fatty acid binding protein 4 as non-invasive brain tumor biomarkers
A Ghorbani, MK Chatanaka, LM Avery, M Wang… - Clinical Proteomics, 2024 - Springer
Background Gliomas are aggressive malignant tumors, with poor prognosis. There is an
unmet need for the discovery of new, non-invasive biomarkers for differential diagnosis …
unmet need for the discovery of new, non-invasive biomarkers for differential diagnosis …
[HTML][HTML] Targeting Glioblastoma: Advances in Precision Drug Delivery
AT Rajendran… - Journal of Young …, 2024 - jyoungpharm.org
Glioblastoma Multiforme (GBM) is still one of the most aggressive and resistant brain
tumours, and current treatment options provide only minimal improvements in survival …
tumours, and current treatment options provide only minimal improvements in survival …
Investigation of Heterogeneity and Stemlike Cell Drivers of Oncogenesis in Pediatric High Grade Glioma
J DeSisto - 2023 - search.proquest.com
Pediatric high-grade gliomas (PHGG) are aggressive CNS tumors with five-year survival
rates of 2% to 20% depending upon subtype. Consistently effective drug therapies have not …
rates of 2% to 20% depending upon subtype. Consistently effective drug therapies have not …
Molecular Determinants of Diffuse Midline Glioma of the Pons Vulnerability to the Histone Deacetylase Inhibitor, Quisinostat
D Paine - 2023 - search.proquest.com
Abstract Diffuse Midline Glioma of the Pons (DMG/Pons) represents a highly aggressive
pediatric high-grade glioma, standing as a predominant cause of brain tumor-related …
pediatric high-grade glioma, standing as a predominant cause of brain tumor-related …